| Biological Information | |
|---|---|
| Background Information: | CCL19 chemoattracts naïve T cells and maturing dendritic cells into the T zones of secondary lymphoid organs. CCL19 controls the cytoarchitecture, rate of endocytosis, survival, apoptosis, migratory speed, and maturation of dendritic cells by binding to the chemokine receptor, CCR7. Provided as 5 μg of dry powder alongside reconstitution buffer. |
| Target Class: | Cytokine |
| Family: | Chemokine |
| Target Name: | CCL19 |
| Usage | |
| Product Type: | Recombinant Proteins |
| Application: | Drug Discovery & Development |
| Storage Conditions: | Store at ≤-20°C. Please avoid multiple freeze/thaw cycles. |
| Usage Disclaimer: | These products may be covered by issued US and/or foreign patents, patent application and subject to Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information. |
| Additional Information | |
| Brand: | DiscoverX |
Recombinant Human CCL19
Recombinant Human CCL19 is an agonist for CCR7. This product is provided as 5μg of dry powder alongside reconstitution buffer.
Datasheets
92-1004 Datasheet
View Document